InsiderClue
Insiders · Profile

JOHNSON JOHN

Director at Xeris Biopharma · Director at Axogen. Filing since 9 Jun 2025. CIK 0001410781

XERS Xeris Biopharma Holdings, Inc. Director · 3 trades AXGN Axogen, Inc. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
XERS Xeris Biopharma Holdings, Inc.
4 Jun 2026
Director
Sold on a plan
15,000
$91.42K
2.1%
AXGN Axogen, Inc.
7 May 2026
Director
Sold at will
11,050
$477.97K
100%
XERS Xeris Biopharma Holdings, Inc.
19 Dec 2025
Director
Sold at will
135,400
$977.02K
16.2%
AXGN Axogen, Inc.
9 Dec 2025
Director
Sold at will
21,686
$650.19K
100%
AXGN Axogen, Inc.
8 Dec 2025
Director
Sold at will
23,693
$740.20K
64.3%
XERS Xeris Biopharma Holdings, Inc.
13 Aug 2025
Director
Sold at will
107,500
$786.46K
11.4%
AXGN Axogen, Inc.
9 Jun 2025
Director
Sold at will
4,073
$43.21K
14.0%
7 decisions on file.